Yıldırım İH, Çakmak EA, Camci C. Gene expression of ING4 gene in pancreatic cancers and splice forms of ING4 gene.

Aktas G, Kus T, Kalender ME, Bakir K, Camci C. A patient with organizing pneumoniadevelopment during the use of Capecitabine maintenance treatment for gastric cancer.

Kus T, Aktas G, Kalender ME, Sevinc A, Camci C. Comparison of FOLFIRINOXChemotherapy with Other Regimens in Patients with Biliary Tract Cancer: RetrospectiveStudy. J Gastrointest Cancer. Journal of

Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer.

Aktas G, Kus T, Kalender ME, Kervancioglu S, Sevinc A, Kul S, Camci C. Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor:

Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulasli M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C.Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients.

Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C. Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel.

Aktas G, Kus T, Kalender ME, Sevinc A, Camci C, Kul S. Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study.

Igci M, Kalender ME, Borazan E, Bozgeyik I, Bayraktar R, Bozgeyik E, Camci C, Arslan A. High-throughput screening of Sirtuin family of genes in breast cancer.

Kus T, Aktas G, Kalender ME, Sari I, Ulker E, Camci C. Collision tumor consisting of primary follicular lymphoma and adenocarcinoma in the cecum: A case report and literatüre review.

Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer.

Kus T, Aktas G, Kalender ME, Tutar E, Ulker E, Camci C. Complete response of a recurrent- metastatic liposarcoma with dedifferentiated histological features following the administration of trabectedin and review of literature.

Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C. Prognostic impact of initial maximum standardized uptake value of (18)F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib.

Kus T, Aktas G, Alpak G, Kalender ME, Sevinc A, Kul S, Temizer M, Camci C. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single- center retrospective case-control study.

Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer.

Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C. Prognostic impact of initial maximum standardized uptake value of 18F-FDGPET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib.

Comez G, Goktepe MF, Oztuzcu S, Sevinc A, Camci C. The isolated extranodal relapse of the isolated extranodal non- Hodgkin lymphoma:

Kus T, Aktas G, Kalender ME, Sevinc A, Kul S, Suner A, Ulker E, Camci C. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study. Support Care Cancer.

Kus T, Aktas G, Sevinc A, Kalender ME, Camci C. Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?

Alptekin M, Eroglu S, Tutar E, Sencan S, Geyik MA, Ulasli M, Demiryurek AT, Camci C. Gene expressions of TRP channels in glioblastoma multiforme and relation with survival.Tumour Biol.

Aykan NF, Yalçın S, Turhal NS, Özdoğan M, Demir G, Özkan M, Yaren A, Camcı C, Akbulut H, Artaç M, Meydan N, Uygun K, Işıkdoğan A, Ünsal D, Özyılkan Ö, Arıcan A, Seyrek E, Tekin SB, Manavoğlu O, Özet A, Elkıran T, Dişçi R. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial).

Kus T, Kalender ME, Aktas G, Suner A, Camci C. Atypical presentation of disseminated intravascular coagulation with synchronous peripheral venous thromboembolism and arterial gangrene in a pancreatic cancer patient: a case report.

Kalender ME, Buyukhatipoglu H, Balakan O, Suner A, Dirier A, Sevinc A, Bulbul F, Tatli AM, Ulas T, Camci C. Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey.

Ergün S, Ulasli M, Igci YZ, Igci M, Kırkbes S, Borazan E, Balik A, Yumrutaş O, Camci C, Cakmak EA, Arslan A, Oztuzcu S. The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer.

Balakan O, Kalender ME, Suner A, Cengiz B, Oztuzcu S, Bayraktar R, Borazan E, Babacan T, Camci C. The relationship between urotensin II and its receptor and the clinicopathological parameters of breast cancer.

Gogebakan B, Bayraktar R, Suner A, Balakan O, Ulasli M, Izmirli M, Oztuzcu S, Camci C. Do fasudil and Y-27632 affect the level of transient receptor potential (TRP) gene expressions in breast cancer cell lines?

Suner A, Buyukhatipoglu H, Balakan O, Kalender ME, Ulas T, Sevinc A, Camci C. Importance of HER2 Work-Up and Treatment Even in Patients with Poor Performance Status: A Case Report.

Arican A, Bozkurt T, Bozcuk H, Demirkan B, Buyukberber S, Alkis N, Sanli UA, Camci C, Yildiz M, Yucel I, Uygun K, Aslay I, Demiray M, Bese NS, Isikdogan A, Bahat Z, Gemici C, Ozdemir F, Ozdener F, Pekin B. A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey.

Yalcin S, Uslu R, Dane F, Yilmaz U, Zengin N, Buyukunal E, Buyukberber S, Camci C, Sencan O, Kilickap S, Ozdener F, Cevik D. Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: phase III 'Stop and Go' study results–a Turkish Oncology Group Trial.

Işık AF, Sanlı M, Yılmaz M, Meteroğlu F, Dikensoy O, Sevinç A, Camcı C, Tunçözgür B, Elbeyli L. Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies.

Erkutlu I, Cigiloglu A, Kalender ME, Alptekin M, Demiryurek AT, Suner A, Ozkaya E, Ulasli M, Camci C. Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme.

Sari I, Berberoglu B, Ozkara E, Oztuzcu S, Camci C, Demiryurek AT. Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development.

Erkutlu I, Cigiloglu A, Kalender ME, Alptekin M, Demiryurek AT, Suner A, Ozkaya E, Ulasli M, Camci C. Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme.

Sari I, Berberoglu B, Ozkara E, Oztuzcu S, Camci C, Demiryurek AT. Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development.

Seker M, Sevinc A, Yildiz R, Cihan S, Kaplan MA, Gokdurnali A, Dane F, Yaman E, Karaca H, Colak D, Uyeturk U, Bilici A, Ozdemir NY, Kalender ME, Uncu D, Salepci T, Isikdogan A, Benekli M, Ozkan M, Gumus M, Coskun U, Camci C, Oksuzoglu B, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey.

Igci M, Cakmak EA, Oztuzcu S, Bayram A, Arslan A, Gogebakan B, Igci YZ, Cengiz B, Ozkara E, Camci C, Demiryurek AT. Mutational screening of the SOCS3 gene promoter in metastatic colorectal cancer patients.

Kaya AO, Coskun U, Ozkan M, Sevinc A, Yilmaz AU, Gumus M, Unal OU, Ozdemir NY, Alici S, Berk V, Degerli H, Oner MK, Ozturk C, Kefeli U, Camcı C; Anatolian Society of Medical Oncology (ASMO). Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.

Oguz E, Alasehirli B, Pehlivan Y, Onat AM, Oztuzcu S, Ozkara E, Kisacik B, Camci C, Demiryürek AT. Association between Rho-kinase (ROCK2) gene polymorphisms and Behçet's disease.

Altinbas M, Kalender ME, Oven B, Sevinc A, Karaca H, Kaplan MA, Alici S, Arpaci E, Yildiz R, Uncu D, Camci C, Gumus M. Weekly topotecan for recurrent small cell lung cancer – a retrospective Anatolian Medical Oncology Group study.

Kaya AO, Büyükberber S, Ozkan M, Alkiş N, Sevinc A, Ozdemir NY, Alici S, Esbah O, Berk V, Camci C, Ulas A, Coskun U, Benekli M; Anatolian Society of Medical Oncology (ASMO). Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for atients with advanced stage soft tissue sarcoma.

Turk HM, Camci C, Sevinc A, Bukyukberber S, Sari I, Adli M. Cyclooxygenase-2 expression is ot a marker of poor survival in lung cancer.

Freedman JE, Ercan B, Morin KM, Liu CT, Tamer L, Ayaz L, Kanadasi M, Cicek D, Seyhan AI, Akilli RE, Camci C, Cengiz B, Oztuzcu S, Tanriverdi K.The distribution of circulating microRNA and their relation to coronary disease.

Camci C, Sahin A, Sevinc A, Kalender ME, Oztuzcu S, Sever ON, Ozkara E, Demiryürek AT. Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients.

Turkbeyler IH, Pehlivan Y, Comez G, Pehlivan D, Sevinc A, Kalender ME, Karakok M, Camci C. Esophagus cancer and IgA deficiency in a patient with Dubowitz syndrome: a case report.

Pehlivan Y, Sevinc A, Turkbeyler IH, Dirier A, Kalender ME, Camci C. Another cause of pancytopenia in a patient receiving temozolomide.

Pehlivan S, Ovayolu O, Ovayolu N, Sevinc A, Camci C. Relationship between hopelessness, loneliness, and perceived social support from family in Turkish patients with cancer.

Comez G, Sevinc A, Sever ON, Babacan T, Sarı I, Camci C. An unusual case of aplastic anemia caused by temozolomide.

Sevinc A, Camci C, Sari I, Kalender ME, Er O, Soyuer I, Dikilitas M, Yilmaz U, Sagol O, Alacacioglu A. Cyclooxygenase-2 expression in gastrointestinal stromal tumours.

Demiryurek AT, Erbagci I, Oztuzcu S, Alasehirli B, Ozkara E, Seker M, Sönmez A, Ozsan M, Camci C. Lack of association between the Thr431Asn and Arg83Lys polymorphisms of the ROCK2 gene and diabetic retinopathy.

Kalender ME, Demiryürek S, Oztuzcu S, Kizilyer A, Demiryürek AT, Sevinc A, Dikilitas M, Yildiz R,Camci C. Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer.

Smith IE, Pierga JY, Biganzoli L, Cortés-Funes H, Thomssen C, Pivot X, Fabi A, Xu B, Stroyakovskiy D, Franke FA, Kaufman B, Mainwaring P, Pienkowski T, De Valk B, Kwong A, González-Trujillo JL, Koza I, Petrakova K, Pereira D, Pritchard KI; ATHENA Study Group. First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.

Kalender ME, Comez G, Sevinc A, Dirier A, Camci C. Leech therapy for symptomatic relief of cancer pain.

Kalender ME, Camci C, Sevinc A. Limited efficacy of Cisplatin, UFT and Hydroxyurea treatment in a retrospective evaluation of patients with metastatic gastric cancer.

Yildiz R, Kalender ME, Dane F, Sevinc A, Gumus M, Camci C, Alici S, Kaya AO, Yaman E, Ozturk B, Coskun U, Benekli M, Uncu D, Buyukberber S. Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.

Arikan-Sengul C, Pehlivan Y, Sevinc A, Karakok M, Kalender ME, Camci C. A Case of Metachronous Triple Primary Urogenital Cancer: Urinary Bladder, Prostate, and Renal Cancer.

Coskun U, Alkis N, Celenkoglu G, Buyukberber S, Ozkan M, Camci C, Uner A, Er O, Aslan UY, Sevinc A, Tokluoglu S, Ozturk B, Yildiz R, Benekli M; Anatolian Society of Medical Oncology. Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer.

Buyukberber N, Buyukberber S, Sevinc A, Camci C. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.

Helvaci MR, Sevinc A, Camci C, Yalcin A.Treatment of white coat hypertension with metformin.

Alacacioglu A, Somali I, Simsek I, Astarcioglu I, Ozkan M, Camci C, Alkis N, Karaoglu A, Tarhan O, Unek T, Yilmaz U. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.

Kalender ME, Sevinc A, Yilmaz M, Ozsarac C, Camci C.Detection of complete response to imatinib mesylate (Glivec((R))/Gleevec ((R))) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma.

Camci C, Sevinc A, Aslan Y, Kalender ME, Buyukberber S.Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.

Dane F, Turk HM, Sevinc A, Buyukberber S, Camci C, Tarakcioglu M.Markers of bone turnover in patients with lung cancer.

Adaletli I, Camci C, Sevinc A, Urger E, Ozer H, Sari I. Isolated bone marrow natural killer cell lymphoma with central nervous system involvement mimicking a cerebral infarct.

Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkis N, Coskun U, Camci C, Buyukberber S. Gemcitabine plus Capecitabine Combination in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines and Taxanes.

Kalender ME, Sevinc A, Camci C, Turk HM, Karakok M, Akgul B.Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.

Comez G, Pehlivan Y, Kalender ME, Sevinc A, Sari I, Camci C. Synchronous Hodgkin’s disease and gastric adenocarcinoma.

Sevinc A, Camci C, Yilmaz M, Buyukhatipoglu H.The diagnosis of C-kit negative GIST by PDGFRA staining: clinical, pathological, and nuclear medicine perspective.

Sevinc A, Adli M, Kalender ME, Camci C.Benign causes of increased serum CA-125 concentration.

Buyukberber S, Sari I, Camci C, Buyukberber NM, Sevinc A, Turk HM. Adrenomedullin expression does not correlate with survival in lung cancer.

Kalender ME, Sevinc A, Tutar E, Sirikci A, Camci C. Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: a case report.

Zincirkeser S, Sevinc A, Kalender ME, Camci C. Early detection of response to imatinib therapy for gastrointestinal stromal tumor by using 18F-FDG-positron emission tomography and computed tomography imaging.

Buyukhatipoglu H, Sevinc A, Pehlivan Y, Camci C.Is prophylactic cranial irradiation a possible option for human epidermal growth factor receptor 2-positive breast cancer?

Buyukhatipoglu H, Sevinc A, Camci C, Buyukberber S, Sari I. case representing coexistence of acute myeloblastic leukemia and dedifferentiated liposarcoma: the possible role of chemotherapy in triggering dedifferentiation.

Yilmaz M, Camci C, Sari I, Okan V, Sevinc A, Onat AM, Büyükhatipoglu H. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto's disease) mimicking systemic lupus erythematosus: a review of two cases.

Pehlivan Y, Sevinc A, Sari I, Gulsen MT, Buyukberber M, Kalender ME, Camci C. An interesting cause of esophageal ulcer etiology: Multiple myeloma of IgG kappa subtype.

Buyukberber M, Sevinc A, Cagliyan CE, Gulsen MT, Sari I, Camci C. Non-Hodgkin lymphoma with high adenosine deaminase levels mimicking peritoneal tuberculosis: An unusual presentation.

Cetin M, Buyukberber S, Demir M, Sari I, Sari I, Deniz K, Eser B, Altuntas F, Camci C, Ozturk A, Turgut B, Vural O, Unal A. Overexpression of cyclooxygenase-2 in multiple myeloma: Association with reduced survival.

Yasa MH, Bektas A, Yukselen V, Akbulut H, Camci C, Ormeci N. DNA analysis and DNA ploidy in gastric cancer and gastric precancerous lesions.

Sevinc A, Camci C, Buyukberber S. Time is up! Acta Clin Belg. 2005 Mar-Apr; 60(2):106-7. Karaca M, Sevinc A, Aydin A, Gocmen A, Buyukberber S, Camci C, Sari I. Female adnexal tumor of probable Wolffian origin diagnosed during the staging evaluation of extranodal diffuse large B-cell lymphoma.

Sevinc A, Buyukberber S, Camci C. Medical jargon: obstacle to effective communication between physicians and patients.

Sevinc A, Buyukberber N, Camci C, Buyukberber S, Karsligil T. Thrombocytopenia in brucellosis: case report and literature review.

Sevinc A, Buyukberber S, Camci C, Koruk M, Savas MC, Turk HM, Sari I, Buyukberber NM. Granulocytic sarcoma of the colon and leukemic infiltration of the liver in a patient presenting with hematochezia and jaundice.

Erkilic S, Erbagci Z, Kocer NE, Bayazit YA, Camci C. Cutaneous involvement in Hodgkin’slymphoma: report of two cases.

Bayazit YA, Buyukberber S, Sari I, Camci C, Ozer E, Sevinc A, Karakok M, Kanlikama M, Mumbuc S. Cyclo-oxygenase 2 expression in laryngeal squamous cell carcinoma and its clinical correlates.

Sevinc A, Buyukberber S, Camci C. Cardiotoxic drugs in breast cancer. J

Turk HM, Buyukberber S, Camci C, Sevinc A, Tuncozgur B, Sivrikoz C, Kervancioglu R, Sari I. Intralobar pulmonary sequestration in a patient with non-Hodgkin's lymphoma: a cause of confusion.

Camci C, Understanding Colon Cancer- Book Rewiev.

Turk HM, Pekdemir H, Buyukberber S, Sevinc A, Camci C, Kocabas R, Tarakcioglu M, Buyukberber NM. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid.

Sevinc A, Camci C, Turk HM, Buyukberber S. How to Interpret Serum CA 125 Levels in Patients with Serosal Involvement?

Camci C, Turk HM, Erkilic S, Buyukberbe S, Uner A, Ozsarac C. Early multimodal therapy in adult Wilms' tumor: case report.

Camci C, Turk HM, Erkilic S, Buyukberbe S, Uner A, Ozsarac C. Early multimodal therapy in adult Wilms' tumor: case report.

Camci C, Buyukberber S, Tarakcioglu M, Adam SM, Camci C, Turk HM, Buyukberber N, Balat O. The effect of continuous ambulatory peritoneal dialysis on serum CA-125 levels.

Camci C, Balat O. Neoadjuvant chemotherapy in ovarian cancer.

Camci C, Guney C, Balkan A, Buyukberber N, Buyukberber S, Kadayifci A, Kubar A. The prevalence of TT virus in cancer patients.

Turk HM, Camci C, Buyukberber S, Tuncozgur B, Sivrikoz C, Elbeyli L, Sari I. Superior vena cava syndrome caused by chemotherapy-induced fibrosis.

Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savli H, Bayraktar N. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus.

Okan V, Araz M, Camci C, Aktaran S, Sahin A, Buyukberber S, Bakir K, Cakmak EA. Bernard-Soulier syndrome in a Turkish family.

Tarakcioglu M, Erbagci A, Cekmen M, Usalan C, Cicek H, Ozaslan J, Camci C. Acute effect of haemodialysis on serum markers of myocardial damage.

Camci C, Turk HM, Buyukberber S, Karakok M, Koruk M, Beyazity Y, Inaloz HS. Colon carcinoma with synchronous subcutaneous and osseous metastasis: a case report

Camci C, Sari R, Buyukberber S, Kutlu R, Sevinc A, Cokkeser Y. Non-invasive imaging methods before fine-needle aspiration in the diagnosis of cervical masses.

Balat O, Aydin A, Camci C, Kutlar I, Buyukberber S. Bilateral primary squamous cell carcinoma of the ovary: a case report of isolated metastasis to the lateral pelvic wall.

Balat O, Aydin A, Kutlar I, Camci C. Ruptured granulosa cell tumor of the left ovary and mature cystic teratoma of the right ovary:a case report of unusual acute abdominal syndrome.

Sari R, Camci C, Kutlu R, Totan Y, Sevinc A, Buyukberber S. The efficacy of acetazolamide on visual functions in a patient with choroid metastasis of breast carcinoma.

Camci C, Sari R, Sevinc A, Buyukberber S. Dacarbazine-induced carotid artery and deep venous thrombosis in a patient with leiomyosarcoma:

Kadikoylu G, Ayhan M, Bolaman AZ, Sonmez HM, Camci C, Senturk T. Congenital dyserythropoietic anemia type 1 with positive acidified hemolysis test.

Bolaman Z, Camci C, Sonmez HM, Kadikoylu G, Muftuoglu E. High dose methylprednisolone therapy before splenectomy for chronic idiopathic thrombocytopenic purpura.

Sari R, Camci C, Sevinc A, Demirbilek O, Ertas E, Buyukberber S. The effect of abdominal surgery on serum CA-125 levels.

Sevinc A, Sari R, Camci C, Buyukberber S. A secondary interpretation is needed on serum CA 125 levels in case of serosal involvement.

Sonmez HM, Basak O, Camci C, Baltaci R, Karazeybek HS, Yazgan F, Ertin I, Celik SC. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydin, Turkey.

Camci C, Paydas S, Sahin B, Cosar E. Malignant lymphoma with severe hypoglycemia.

Aykan NF, Yalçın Ş, Turhal NS, Özdoğan M, Demir G, Özkan M, Yaren A, Camcı C, et al. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial).

Akkafa F, Arslan A, Öztuzcu S, Özardalı Hİ, Gökalp A, Özkara E, Bozdağ Z, Camcı C, Aytekin A. Meme kanserlerinde HtrA2 gen ifadesinin analizi.

Ulaşlı M, Gürses S, Cengiz B, Öztuzcu S, Balakan O, Süner A, Göğebakan, B, İğci M, Balık A, Arslan A, Camcı C. Expression of PARP1 gene in breast cancer patients.

Camcı C, Kalender ME, Paydas S, Sevinc A, Zorludemir S, Suner A. Meme kanserinde Wilms Tümör 1 (WT1) protein ekpresyonunun prognostik önemi.

Kalender ME, Demiryürek Ş, Öztuzcu S, Kızılyer A, Demiryürek AT, Balakan O, Camcı C. ROCK 1 geni Lys222GLU ve Arg1262GLN polimorfizmleri ile meme kanseri arasındaki ilişkinin araştırılması.

Çömez G, Pehlivan Y, Sevinç A, Kervancıoğlu S, Sarıca MA, Tutar E, Camcı C. Maksiller sinüs tutulumlu ekstramedüller palasmositom: Genç bir olgu sunumu. Uluslararası Hematoloji-Onkoloji Dergisi 2008; 18(2): 112-115. Camcı C. Malign perikardiyal effüzyonlar.

Kalender ME, Sevinç A, Tutar E, Camcı C. Senkron renal hücreli karsinom ve meme medüller karsinom birlikteliği.

Sevinç A, Türk, HM, Camcı C. Topotekan.

Camcı C, Sevinç A, Sarı R, Büyükberber S. Hemodiyaliz ve periton diyaliz hastalarında serum Protein C, Protein S ve Antitrombin III düzeyleri.

Camcı C, Paydaş S, Tanrıverdi K. Lösemilerde nm23-H1 ve nm23-H2 mRNA ekspresyonunun RT-PCR yöntemi ile incelenmesi.

Özbek E, Mızrak B, Özbek M, Camcı C. Mesane kanserinde inducible nitrit oksit ekspresyonu.

Camcı C, Büyükberber N, Büyükberber S, Harputluoğlu M, Ak G, Sarı R. Düşük riskli febril nötropenide antibiyotik protokollerinin karşılaştırılması.

Camcı C, Sarı R, Sevinç A, Büyükberber S. Temporary diffuse hyperpigmentation induced by weekly 5-Fluorouracil and Leucovorin chemotherapy.

Kadıköylü G, Ayhan M, Bolaman Z, Sönmez HM, Camcı C, Şentürk T. Asit hemoliz testi pozitif tip 1 kongenital diseritropoetik anemili bir olgu.

Camcı C, Seyrek E, Sönmez H.M, Çiçek C, Özgel N, Bolaman Z. İki olgu nedeniyle feokromositoma.

Camcı C, Yaşa MH. Helicobacter pylori ve mide kanseri.

Camcı C, Bolaman Z, Sönmez HM, Öge A, Çiçek C, Yavaşoğlu İ. Gebeliğe bağlı Coombs negatif hemolitik anemi.

Özet A, Arpacı F, Öztürk B, Camcı C, Safalı M, Kömürcü Ş, Güleç B, Yılmaz İ, Ayta H, Yavuz AA, Pak Y, Yücel İ, Yalçın A. Results of high dose chemotherapy (HDC) and autologous peripheral blood stem cell transplantation (APBSCT) in 45 patients with breast cancer.

Camcı C, Paydaş S, Zorludumir S, Hazar B, Şahin B. Immunohisto-chemical analysis of prostate spesific antigen in breast cancer and correlation with clinical parameters.

Yaşa MH, Bektaş A, Akbulut H, Camcı C, Örmeci N. Mide karsinomları ve prekanseröz mide lezyonlarının DNA analizi ve DNA ploidi ile ilişkisi.

Camcı C, Paydaş S, Şahin B, Hazar B. A single center randomized study comparing the efficacy of Ciprofloxacin+Amikacin vs Imipenem/Cilastatin in febrile neutropenic patients.

Kadıköylü G, Camcı C, Sönmez HM, Öge A, Bolaman Z, Şentürk T. Tip-II diabette asemptomatik kolelitiazis sıklığı.

Sönmez HM, Başak O, Camcı C, Baltacı R, Karazeybek HŞ, Yazgan F, Ertin İ, Çelik SÇ. Aydın yöresinde resmi sağlık kurumlarının hipertansiyon tanısı ve sağaltımındaki etkinliği.

Camcı C, Bolaman Z, Sönmez HM, Öge A, Çiçek C, Yavaşoğlu İ. Gebeliğe bağlı Coombs negatif hemolitik anemi.

Sönmez HM, Başak O, Camcı C, Baltacı R, Karazeybek HŞ, Yazgan F. Aydın yöresinde on yedi yaş üstü kitlede sigara içimi ve hipertansiyonla birlikteliği.

Bolaman Z, Camcı C, Sönmez HM, Öge A, Kadıköylü G, Tuncer G. Transfüzyonla ilgili akut akciğer hasasında yüksek doz intravenöz metilprednizolon tedavisi.

Akyol A, Bölükbaşı O, Genel H, Camcı C. Trousseau Sendromu.

Camcı C. Bir tümör süpresör gen:

Camcı C, Tanrıverdi S, Paydaş S, Özcan K. Blastocystis Hominis in a leukemia patient.

Şahna K, Camcı C, Şirin S, Tunç ŞE, Gölbaşı Z, Pürsünlerli G. Sol ventrikül diyastolik doluşu üzerine hemodializin etkisinin doppler ekokardiyografi ile değerlendirilmesi.

Özet G, Yılmaz Ö, Camcı C, Tülce E, Özet A, Esen M, Pürsünlerli G. Q ve Non-Q myokart infarktüslerinde risk faktörleri, klinik seyir ve prognoz.

Yılmaz Ö, Özet G, Camcı C. Kronik anemili hastalarda sol ventrikül sistolik ve diyastolik fonksiyonlarının ekokardiyografik olarak değerlendirilmesi.

Şahna K, Navruz MZ, Camcı C, Şirin S, Tunç ŞE, Pürsünlerli G. Genç yaş akut myokart infarktüslerinde Apolipoprotein A1 ve Apolipoprotein B’nin tayini.

Yılmaz Ö, Camcı C, Şahna K, Şirin S, Navruz MZ, Tülce E, Pürsünlerli G. Yatak başında geçici pacemaker uygulaması.

Navruz MZ, Yılmaz Ö, Camcı C, Tülce E, Pürsünlerli G. Pulmoner arter sistolik basıncının değerlendirilmesinde pulmoner ve triküspit kapak akımlarının pulsed doppler ekokardiyografi ile incelenmesi.

Yılmaz Ö, Navruz MZ, Camcı C, Özet G, Pürsünlerli G. Akut myokart infarktüsünde sağ ventrikül fonksiyonlarının pulsed-doppler ekokardiyografi ile değerlendirilmesi.

Yılmaz Ö, Navruz MZ, Camcı C, Pürsünlerli G. Hafif ve orta dereceli hipertansiyonlu hastalarda sol ventrikül fonksiyonlarının ekokardiyografik olarak incelenmesi.

Navruz MZ, Tülce E, Şahna K, Camcı C, Esen M, Pürsünlerli G. Akut myokart infarktüsünde serum myoglobin düzeyi.

Uluslararası kongrelerde sunulmuş ve bildiri kitabında yayınlanmış olan araştırmalar:

Ulusal kongrelerde sunulmuş ve bildiri kitabında yayınlanmış olan araştırmalar:

YÖNETİLEN TEZLER: İç Hastalıkları Anabilim Dalı’nda 4, Tıbbi Onkoloji Bilim Dalı’nda

KONUŞMACI OLARAK KATILDIĞIM KONGRE, SEMPOZYUM VE TOPLANTILAR:

Primer Araştırmacı (Principal Investigator) olduğum çalışmalar:

Gaziantep Üniversitesi BAP (Bilimsel Araştırma Projeleri) kapsamında yürütücü/yardımcı araştırmacı olduğum projeler:

1.YÜRÜTTÜĞÜM PROJELER a. Primer Araştırmacı (Principal Investigator) olduğum çalışmalar:

1.YÜRÜTTÜĞÜM PROJELER b. Gaziantep Üniversitesi BAP (Bilimsel Araştırma Projeleri) kapsamında yürütücü/yardımcı araştırmacı olduğum projeler: